{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:12:00Z","timestamp":1793218320718,"version":"4.5.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is characterized by over 5% hepatic fat accumulation without secondary causes. The prevalence of NAFLD has escalated in recent years due to shifts in dietary patterns and socioeconomic status, making it the most prevalent chronic liver disease and a significant public health concern globally. Serum uric acid (SUA) serves as the end product of purine metabolism in the body and is intricately linked to metabolic syndrome. Elevated SUA levels have been identified as an independent risk factor for the incidence and progression of NAFLD. This paper reviews the relationship between SUA and NAFLD, the underlying mechanisms of SUA involved in NAFLD, and the potential benefits of SUA-lowering therapy in treating NAFLD. The aim is to raise awareness of SUA management in patients with NAFLD, and to encourage further investigation into pharmacological interventions in this area.<\/jats:p>","DOI":"10.3389\/fendo.2024.1455132","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:42:18Z","timestamp":1732779738000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Serum uric acid and nonalcoholic fatty liver disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Jia","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/nu15061355","article-title":"In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease","volume":"15","author":"Lv","year":"2023","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12944-020-01274-y","article-title":"Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice","volume":"19","author":"Tsai","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41420-022-01011-7","article-title":"Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discovery"},{"key":"B4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12876-023-02708-4","article-title":"Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study","volume":"23","author":"Cong","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30426","article-title":"Analysis of a simulation model to estimate long-term outcomes in patients with nonalcoholic fatty liver disease","volume":"5","author":"Chhatwal","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19069","article-title":"Extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"14","author":"Li","year":"2020","journal-title":"Gut Liver"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5180242","article-title":"4-octyl itaconate prevents free fatty acid-induced lipid metabolism disorder through activating nrf2-AMPK signaling pathway in hepatocytes","volume":"2022","author":"Chu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3350\/cmh.2021.0371","article-title":"Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study","volume":"28","author":"Lee","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1254014","article-title":"Advance of serum biomarkers and combined diagnostic panels in nonalcoholic fatty liver disease","volume":"2022","author":"Zeng","year":"2022","journal-title":"Dis Markers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1038\/s41598-020-66205-4","article-title":"Molecular and histopathological study on the ameliorative impacts of petroselinum crispum and apium graveolens against experimental hyperuricemia","volume":"10","author":"Soliman","year":"2020","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00049","article-title":"Mangiferin ameliorates hyperuricemic nephropathy which is associated with downregulation of AQP2 and increased urinary uric acid excretion","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835d951e","article-title":"Metabolic syndrome, diabetes, and hyperuricemia","volume":"25","author":"Li","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr Pharm Des"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2016.11.004","article-title":"Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review","volume":"8","author":"Sharaf El Din","year":"2017","journal-title":"J Adv Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2012.08.013","article-title":"Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey","volume":"62","author":"Sirota","year":"2013","journal-title":"Metabolism"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: A dose-response meta-analysis of prospective studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051445","article-title":"Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It","volume":"11","author":"Yen","year":"2022","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S403314","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"15","author":"Sun","year":"2023","journal-title":"Clin Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/br.2016.698","article-title":"Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease","volume":"5","author":"Huang","year":"2016","journal-title":"BioMed Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23717","article-title":"Association between serum uric acid level and chronic liver disease in the United States","volume":"52","author":"Afzali","year":"2010","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12734","article-title":"Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults","volume":"47","author":"Liu","year":"2017","journal-title":"Hepatol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_484_22","article-title":"Combining serum uric acid and fatty liver index to improve prediction quality of nonalcoholic fatty liver disease","volume":"29","author":"Ding","year":"2023","journal-title":"Saudi J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2478\/abm-2022-0003","article-title":"Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans","volume":"16","author":"Park","year":"2022","journal-title":"Asian BioMed (Res Rev News)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173587","article-title":"The additive values of the classification of higher serum uric acid levels as a diagnostic criteria for metabolic-associated fatty liver disease","volume":"14","author":"He","year":"2022","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e13022","DOI":"10.7717\/peerj.13022","article-title":"A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study","volume":"10","author":"Wang","year":"2022","journal-title":"PeerJ"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6687626","article-title":"No evidence for a causal link between serum uric acid and nonalcoholic fatty liver disease from the dongfeng-tongji cohort study","volume":"2022","author":"Tang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/17843286.2020.1783907","article-title":"Non-alcoholic fatty liver disease: correlation with hyperuricemia in a European Mediterranean population","volume":"77","author":"Catanzaro","year":"2022","journal-title":"Acta Clin Belg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10691","article-title":"The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study","volume":"9","author":"Hu","year":"2021","journal-title":"PeerJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12876-021-01782-w","article-title":"Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107874","article-title":"Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population","volume":"35","author":"Cui","year":"2021","journal-title":"J Diabetes Complications"},{"key":"B35","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1038\/s41598-020-66931-9","article-title":"Association between serum uric acid and nonalcoholic fatty liver disease in nonobese postmenopausal women: A cross-sectional study","volume":"10","author":"Bao","year":"2020","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12967-020-02296-x","article-title":"Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study","volume":"18","author":"Ma","year":"2020","journal-title":"J Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00179","article-title":"Higher serum uric acid level predicts non-alcoholic fatty liver disease: A 4-year prospective cohort study","volume":"11","author":"Wei","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.10.001","article-title":"Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center","volume":"13","author":"Sandra","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B39","article-title":"Association of non-alcoholic fatty liver disease with serum uric acid","volume":"31","author":"Abbasi","year":"2019","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090600","article-title":"Relationship between serum uric acid levels and nonalcoholic fatty liver disease in non-obese patients","volume":"55","author":"Oral","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2018.04.008","article-title":"Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study","volume":"26","author":"Bai","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12967-018-1657-6","article-title":"Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study","volume":"16","author":"Yang","year":"2018","journal-title":"J Transl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192396","article-title":"Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study","volume":"13","author":"Yang","year":"2018","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-017-0531-5","article-title":"Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults","volume":"16","author":"Zheng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008164","article-title":"Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study","volume":"96","author":"Yu","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177249","article-title":"Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study","volume":"12","author":"Yang","year":"2017","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166072","article-title":"Associations between serum uric acid and the remission of non-alcoholic fatty liver disease in chinese males","volume":"11","author":"Zhou","year":"2016","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.7869\/tg.334","article-title":"Elevated levels of serum uric acid and insulin resistance are associated with nonalcoholic fatty liver disease among prediabetic subjects","volume":"37","author":"Hossain","year":"2016","journal-title":"Trop Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140379","article-title":"Liver fat content is associated with elevated serum uric acid in the chinese middle-aged and elderly populations: shanghai changfeng study","volume":"10","author":"Lin","year":"2015","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000802","article-title":"Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study","volume":"94","author":"Wu","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2012.11.014","article-title":"Association between serum uric acid and nonalcoholic fatty liver disease in the US population","volume":"114","author":"Shih","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"B53","article-title":"Serum uric acid and non-alcoholic fatty liver disease in non-hypertensive Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study","volume":"19","author":"Liang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.926323","article-title":"Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women","volume":"17","author":"Liu","year":"2014","journal-title":"Climacteric"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.01.029","article-title":"The relationship of serum uric acid with non-alcoholic fatty liver disease","volume":"47","author":"Sertoglu","year":"2014","journal-title":"Clin Biochem"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067152","article-title":"Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men","volume":"8","author":"Xie","year":"2013","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302013000800006","article-title":"Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China","volume":"57","author":"Cai","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2011.26.3.386","article-title":"The relationship between normal serum uric acid and nonalcoholic fatty liver disease","volume":"26","author":"Hwang","year":"2011","journal-title":"J Korean Med Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.08.005","article-title":"Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men","volume":"60","author":"Ryu","year":"2011","journal-title":"Metabolism"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011578","article-title":"High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study","volume":"5","author":"Xu","year":"2010","journal-title":"PloS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3109\/03009741003742797","article-title":"Gout and risk of non-alcoholic fatty liver disease","volume":"39","author":"Kuo","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.11.021","article-title":"Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study","volume":"50","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B64","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12906-022-03794-9","article-title":"Water extract from artichoke ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats","volume":"22","author":"Deng","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6889533","article-title":"The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD","volume":"2021","author":"Hong","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1617805","article-title":"Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00518.2020","article-title":"High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signaling","volume":"320","author":"Xie","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i15.1683","article-title":"Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review","volume":"26","author":"Brennan","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b04079","article-title":"Multitargeting antibacterial activity of a synthesized mn2+ Complex of curcumin on gram-positive and gram-negative bacterial strains","volume":"5","author":"Saha","year":"2020","journal-title":"ACS Omega"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00443.2014","article-title":"The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model","volume":"309","author":"Nakatsu","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2018.11.008","article-title":"The extra-splanchnic fructose escape after ingestion of a fructose-glucose drink: An exploratory study in healthy humans using a dual fructose isotope method","volume":"29","author":"Francey","year":"2019","journal-title":"Clin Nutr ESPEN"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J Biol Chem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1018572","article-title":"Potential hepatoprotective effects of Cistanche deserticola Y.C. Ma: Integrated phytochemical analysis using UPLC-Q-TOF-MS\/MS, target network analysis, and experimental assessment","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309128","article-title":"Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-\u03baB signaling pathway in hepG2 cells","volume":"37","author":"Spiga","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01728","article-title":"Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease","volume":"8","author":"Wu","year":"2017","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40124","article-title":"Uric acid promotes an acute inflammatory response to sterile cell death in mice","volume":"120","author":"Kono","year":"2010","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J Hepatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931087","article-title":"Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-065X.2011.01040.x","article-title":"Innate and adaptive immune responses to cell death","volume":"243","author":"Rock","year":"2011","journal-title":"Immunol Rev"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010042","article-title":"Lactoferrin prevents hepatic injury and fibrosis via the inhibition of NF-\u03baB signaling in a rat non-alcoholic steatohepatitis model","volume":"14","author":"Aoyama","year":"2021","journal-title":"Nutrients"},{"key":"B84","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12967-023-04050-5","article-title":"Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism","volume":"21","author":"Lou","year":"2023","journal-title":"J Transl Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2014.98","article-title":"Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes","volume":"94","author":"Choi","year":"2014","journal-title":"Lab Invest"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13063","article-title":"The relationship between serum uric acid levels and the major risk factors for the development of nonalcoholic fatty liver disease","volume":"36","author":"Ozcelik","year":"2016","journal-title":"Liver Int"},{"key":"B87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biochi.2015.06.025","article-title":"Uric acid as a modulator of glucose and lipid metabolism","volume":"116","author":"Lima","year":"2015","journal-title":"Biochimie"},{"key":"B88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12876-020-01189-z","article-title":"Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p\/FGF21 axis","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20200384","article-title":"Combined associations of liver enzymes and obesity with diabetes mellitus prevalence: the tohoku medical megabank community-based cohort study","volume":"32","author":"Itabashi","year":"2022","journal-title":"J Epidemiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9537741","article-title":"The effects of C. lacerata on insulin resistance in type 2 diabetes patients","volume":"2022","author":"Choi","year":"2022","journal-title":"J Diabetes Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nri2449","article-title":"Nutrient sensing and inflammation in metabolic diseases","volume":"8","author":"Hotamisligil","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0976","article-title":"Mechanisms of macrophage activation in obesity-induced insulin resistance","volume":"4","author":"Odegaard","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2337\/dsi23-0013","article-title":"Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care","volume":"37","author":"Nogueira","year":"2024","journal-title":"Diabetes SpectrI"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006158","article-title":"Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats","volume":"294","author":"Sanchez-Lozada","year":"2019","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1253\/circj.69.928","article-title":"Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome","volume":"69","author":"Yoo","year":"2005","journal-title":"Circ J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S362248","article-title":"Relationship between four non-insulin-based indexes of insulin resistance and serum uric acid in patients with type 2 diabetes: A cross-sectional study","volume":"15","author":"Han","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28468","article-title":"Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment","volume":"10","author":"Savari","year":"2024","journal-title":"Heliyon"},{"key":"B102","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2018.05.024","article-title":"Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score","volume":"14","author":"Tan","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v11.i2.138","article-title":"Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects","volume":"11","author":"Laursen","year":"2019","journal-title":"World J Hepatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115640","article-title":"Metabolic dysfunction-associated steatotic liver disease: from pathogenesis to current therapeutic options","volume":"25","author":"Portincasa","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113074","article-title":"Allopurinol versus febuxostat: A new approach for the management of hepatic steatosis in metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"Al-Shargi","year":"2023","journal-title":"Biomedicines"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9682-5","article-title":"Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol Int"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1096930","article-title":"Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease","volume":"20","author":"Sun","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2023.155","article-title":"The therapeutic effect of allopurinol in fatty liver disease in rats","volume":"19","author":"Bari\u015fik","year":"2023","journal-title":"Acta Endocrinol (Buchar)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211031417","article-title":"Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2","volume":"35","author":"Zeng","year":"2021","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12226","article-title":"Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats","volume":"169","author":"Wang","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/toxsci\/kfab034","article-title":"Allopurinol protects against cholestatic liver injury in mice not through depletion of uric acid","volume":"181","author":"Liu","year":"2021","journal-title":"Toxicol Sci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"9894","DOI":"10.1038\/s41598-021-88872-7","article-title":"Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway","volume":"11","author":"Cho","year":"2021","journal-title":"Sci Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180761","article-title":"Hepatic safety of febuxostat compared with allopurinol in gout patients with fatty liver disease","volume":"46","author":"Lee","year":"2019","journal-title":"J Rheumatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41598-020-57784-3","article-title":"Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice","volume":"10","author":"Nishikawa","year":"2020","journal-title":"Sci Rep"},{"key":"B117","article-title":"The involvement and mechanism of febuxostat in non-alcoholic fatty liver disease cells","volume":"32","author":"Tang","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"key":"B118","doi-asserted-by":"publisher","first-page":"80","DOI":"10.32725\/jab.2023.009","article-title":"Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5\/Dmcr rats","volume":"21","author":"Kakimoto","year":"2023","journal-title":"J Appl BioMed"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1455132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:42:23Z","timestamp":1732779743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1455132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":118,"alternative-id":["10.3389\/fendo.2024.1455132"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1455132","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"article-number":"1455132"}}